Expert Insights: Long-Term Potential of Sanofi India Shares
Market expert Chandan Taparia provides a detailed analysis and long-term view on Sanofi India shares, offering valuable advice to investors.
Sanofi IndiaStock MarketInvestmentPharmaceuticalsMarket TrendsReal Estate NewsNov 07, 2024
Sanofi India, one of the leading pharmaceutical companies in the country, has seen a significant rally of 24% in recent times. According to Chandan, the stock has the potential to reach ₹7,600 in the long term. However, to achieve this target, it is crucial that the stock stays above the ₹6,800 level. This level acts as a significant supply trendline, and maintaining it is essential for the stock to reach the anticipated ₹7,500 mark.
Chandan advises investors to hold onto their Sanofi India shares if the stock remains above ₹6,800. This strategy ensures that investors can benefit from the expected long-term appreciation. For those who are considering buying, the expert recommends entering above this support level to minimize risk.
Daily Calls is designed to help investors of all levels, from seasoned professionals to beginners. Our show offers live insights, hold, buy, and sell recommendations, and expert guidance on other promising investment opportunities in the market. Tune in from Monday to Friday, 12 pm to 1 pm, to get the latest market updates and expert advice.
Sanofi India has a strong presence in the pharmaceutical sector, with a diverse portfolio of products and a robust research and development pipeline. The company's commitment to innovation and quality has made it a trusted name in the industry. For investors looking to diversify their portfolio, pharmaceutical stocks like Sanofi India can offer both stability and growth potential.
Whether you're looking to make informed investment decisions or simply want to stay updated on the latest market trends, Daily Calls is the perfect platform. Join us for expert insights and valuable recommendations that can help you achieve your financial goals.
Frequently Asked Questions
What is the current performance of Sanofi India shares?
Sanofi India shares have rallied 24% in recent times, showing a strong upward trend.
What is the long-term target price for Sanofi India shares?
The long-term target price for Sanofi India shares, as per market expert Chandan Taparia, is ₹7,600.
What is the recommended holding level for Sanofi India shares?
Chandan Taparia advises holding Sanofi India shares above the ₹6,800 level to ensure long-term appreciation.
What is the best time to tune in for live market insights and recommendations?
You can tune in to Daily Calls from Monday to Friday, 12 pm to 1 pm, for live market insights and expert recommendations.
Why should investors consider pharmaceutical stocks like Sanofi India?
Pharmaceutical stocks like Sanofi India offer both stability and growth potential, making them a valuable addition to a diversified investment portfolio.
Related News Articles
Javed Akhtar Expands Luxury Property Portfolio with ₹7.8cr Juhu Apartment
Celebrated poet, scriptwriter, and lyricist Javed Akhtar acquires a luxurious apartment in Mumbai's posh Juhu neighborhood, adding to his impressive property portfolio.
NCR Sees a Shift Towards Luxury Housing, Sales of Affordable Units Dip
NCR's housing market is witnessing a trend reversal, with luxury units seeing a significant surge and affordable housing sales dipping. Gurugram leads the pack in luxury home sales.
BJP Government Accused of Running Real Estate Business in Goa, Says Congress
Congress alleges land scam and real estate business by BJP, sacred lakes and water bodies being converted
Deshpande Realty Wins 'Excellence in Redevelopment of Pune' Award
Founded in 2014, Deshpande Realty has quickly established itself as a leading name in Pune's real estate sector, known for its commitment to quality and innovative projects.
ORERA in Odisha Issues Warning: 60 Real Estate Promoters Face Penalties; Full List Revealed
The Odisha Real Estate Regulatory Authority (ORERA) has raised concerns and released a list of 60 real estate promoters who have been penalized. This list highlights the stringent measures being taken to ensure transparency and accountability in the real
Godrej Properties Sells Rs 28,800 Crore Worth of Properties in 2024, Leads Listed Firms
Godrej Properties has achieved a significant milestone by selling properties worth Rs 28,800 crore in 2024, topping the list of listed firms. The company has launched 30 projects, with the Mumbai Metropolitan Region (MMR) contributing Rs 9,177 crore.